Norris Medicines Board Meeting Date
Norris Medicines Limited intimated a prior board meeting on 14 Nov 2026 to consider unaudited standalone quarterly results for September 2026. Trading window closed from 01 Oct to 16 Nov 2026.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
3 announcements with these filters
Norris Medicines Limited intimated a prior board meeting on 14 Nov 2026 to consider unaudited standalone quarterly results for September 2026. Trading window closed from 01 Oct to 16 Nov 2026.
Norris Medicines Limited has scheduled a board meeting for August 14, 2026, to consider and approve the un-audited financial results for the quarter ended June 30, 2026.
Norris Medicines scheduled a board meeting for May 30, 2026, to approve audited FY26 financial results. The trading window remains closed until 48 hours post-declaration.